Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2009

Jun 10, 2009

33510_dirs_2009-06-10_0d7a7ef8-b5e8-4621-b97e-8b12541dcd87.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2009-06-08

Reporting Person: Woods Lori A (COO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-06-08 Stock option (right to buy) $0.26 A 100000 Acquired 2019-06-08 Common stock (100000) Direct

Footnotes

F1: 33,333 vest on 6/8/10, 33,333 vest on 6/8/11, and 33,334 vest on 6/8/12.